Management Sciences for Health to Strengthen Cameroon’s Medicine Safety Monitoring System

Arlington, VA—December 12, 2022—Management Sciences for Health (MSH) is pleased to announce the launch of a pilot program in Cameroon to improve the country’s ability to detect, assess, monitor, and ultimately prevent adverse effects of pharmaceutical products. The pilot, launched last week at an event in Yaoundé with Cameroon’s Ministry of Public Health’s Directorate for Pharmacy, Medicines, and Laboratories, is made possible with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria and will run through the end of 2023.

The program will strengthen a well-structured drug safety monitoring system—also known as pharmacovigilance—as the country prepares to introduce new medical products, including those for HIV, tuberculosis, malaria, and other infectious diseases.

“Establishing good safety surveillance systems will benefit all medicines including vaccines and medical devices, because the same processes, infrastructure, skills, and tools will be necessary to measure the safety of new medicines for drug-resistant tuberculosis, new combination treatments for HIV, and vaccines—many of which are being introduced in lower income countries first, without the benefit of the surveillance available in high-income countries,” said Alemayehu Duga, Project Technical Lead of the Global Fund Pharmacovigilance Program.

MSH is a recognized leader in pharmaceutical systems strengthening, with 30 years of experience helping low- and middle-income countries take a systems approach to ensuring sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and pharmaceutical services.

For more information, visit www.msh.org